1. Home
  2. RWT vs RLMD Comparison

RWT vs RLMD Comparison

Compare RWT & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwood Trust Inc.

RWT

Redwood Trust Inc.

HOLD

Current Price

$4.74

Market Cap

574.0M

Sector

Real Estate

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$4.96

Market Cap

524.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RWT
RLMD
Founded
1994
2004
Country
United States
United States
Employees
351
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
574.0M
524.9M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
RWT
RLMD
Price
$4.74
$4.96
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$6.82
$12.40
AVG Volume (30 Days)
2.2M
1.5M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
12.83%
N/A
EPS Growth
N/A
45.28
EPS
N/A
N/A
Revenue
N/A
$13,070.00
Revenue This Year
$26.59
N/A
Revenue Next Year
$22.21
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
154.83
52 Week Low
$4.19
$0.55
52 Week High
$6.97
$8.00

Technical Indicators

Market Signals
Indicator
RWT
RLMD
Relative Strength Index (RSI) 36.34 41.64
Support Level $4.44 $4.06
Resistance Level $5.36 $7.28
Average True Range (ATR) 0.16 0.33
MACD -0.03 0.06
Stochastic Oscillator 17.61 71.72

Price Performance

Historical Comparison
RWT
RLMD

About RWT Redwood Trust Inc.

Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: